The executive sold 4,000 shares for $1.7 million on August 17, 2026.
The transaction represented a 3% reduction in total direct equity holdings.
The disposal was conducted through direct ownership and did not involve any indirect entities.
The trade was executed under a Rule 10b5-1 plan established in February 2026, following a 306% one-year return for the stock as of the transaction date.
Gregory Stephen Smith, President and CEO of Teradyne, Inc. (NASDAQ:TER), sold 4,000 shares of common stock on Aug. 17, 2026, according to a SEC Form 4 filing.
| Metric | Value |
|---|---|
| Transaction value | $1.7 million |
| Shares sold (directly held) | 4,000 |
| Post-transaction shares (directly held) | 112,495 |
| Post-transaction value | $49.85 million |
Transaction value based on SEC Form 4 weighted average sale price ($425.00); post-transaction value based on Aug. 17, 2026 market close ($443.14).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-17) | $443.14 |
| Market Capitalization | $69.3 billion |
| Revenue (TTM) | $4.5 billion |
| Net Income (TTM) | $1.2 billion |
Teradyne is a global leader in automated semiconductor testing solutions with a market capitalization of $69.3 billion and TTM revenues of $4.5 billion, demonstrating substantial scale and profitability with TTM net income of $1.2 billion.
The company has experienced significant momentum, with a one-year share price appreciation of 306%, reflecting strong demand for semiconductor test equipment driven by industrywide capacity expansion and advanced node development.
Teradyne's competitive advantage is anchored in its comprehensive portfolio of test platforms, deep customer relationships with major semiconductor manufacturers, and integrated software and services that create switching costs and generate recurring revenue.
This sale shouldn't concern investors. It represented a small percentage of the CEO's total stake and was a pre-planned transaction under a Rule 10b5-1 plan. This is commonly used to allow insiders to make planned sales while avoiding conflicts of interest or the appearance of acting on material non-public information.
Importantly, Teradyne is performing well, with TTM revenue soaring over the past year. This has also fueled a higher margin and earnings.
The stock is not cheap, trading at a high price-to-earnings multiple, yet analysts are also projecting strong earnings growth to continue. The current consensus estimate calls for earnings to grow at an annualized rate of 28% in the coming years.
John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Teradyne. The Motley Fool has a disclosure policy.